MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDA • CA55293N1096

40.43 CAD
-1.18 (-2.84%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

MDA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 13 industry peers in the Aerospace & Defense industry. MDA has only an average score on both its financial health and profitability. MDA is valued quite expensive, but it does show an excellent growth. This makes MDA very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MDA was profitable.
  • In the past year MDA had a positive cash flow from operations.
  • Of the past 5 years MDA 4 years were profitable.
  • Each year in the past 5 years MDA had a positive operating cash flow.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • MDA has a worse Return On Assets (3.15%) than 69.23% of its industry peers.
  • MDA has a better Return On Equity (8.24%) than 84.62% of its industry peers.
  • MDA has a worse Return On Invested Capital (5.12%) than 61.54% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MDA is significantly below the industry average of 9.48%.
  • The last Return On Invested Capital (5.12%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROIC 5.12%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • The Profit Margin of MDA (7.40%) is worse than 61.54% of its industry peers.
  • In the last couple of years the Profit Margin of MDA has grown nicely.
  • Looking at the Operating Margin, with a value of 9.86%, MDA is doing worse than 61.54% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MDA has grown nicely.
  • MDA has a Gross Margin of 24.62%. This is in the better half of the industry: MDA outperforms 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of MDA has declined.
Industry RankSector Rank
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MDA.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
  • The number of shares outstanding for MDA has been increased compared to 1 year ago.
  • Compared to 1 year ago, MDA has an improved debt to assets ratio.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.90 indicates that MDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MDA has a better Altman-Z score (1.90) than 84.62% of its industry peers.
  • The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.92, MDA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.31, MDA is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Altman-Z 1.9
ROIC/WACC0.58
WACC8.87%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
  • With a Current ratio value of 0.55, MDA is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
  • MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MDA has a Quick ratio (0.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.54
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. MDA.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.25% over the past year.
  • The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
  • The Revenue has grown by 57.77% in the past year. This is a very strong growth!
  • MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%

3.2 Future

  • Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.72% on average per year.
  • MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.88% yearly.
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y29.89%
Revenue Next 3Y23.88%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 35.78 indicates a quite expensive valuation of MDA.
  • 69.23% of the companies in the same industry are cheaper than MDA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of MDA to the average of the S&P500 Index (26.29), we can say MDA is valued slightly more expensively.
  • MDA is valuated quite expensively with a Price/Forward Earnings ratio of 26.16.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 61.54% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, MDA is valued at the same level.
Industry RankSector Rank
PE 35.78
Fwd PE 26.16
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than 69.23% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.95
EV/EBITDA 20.75
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.72% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y48.58%
EPS Next 3Y35.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • No dividends for MDA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (3/6/2026, 7:00:00 PM)

40.43

-1.18 (-2.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14
Earnings (Next)03-04
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap5.11B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts80
Price Target48.2 (19.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)18.29%
PT rev (3m)17.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 35.78
Fwd PE 26.16
P/S 3.45
P/FCF 10.95
P/OCF 6.94
P/B 3.84
P/tB N/A
EV/EBITDA 20.75
EPS(TTM)1.13
EY2.79%
EPS(NY)1.55
Fwd EY3.82%
FCF(TTM)3.69
FCFY9.13%
OCF(TTM)5.82
OCFY14.41%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.34
PEG (5Y)N/A
Graham Number16.36
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROCE 7.1%
ROIC 5.12%
ROICexc 5.66%
ROICexgc 60.4%
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
FCFM 31.5%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Debt/EBITDA 1.55
Cap/Depr 226.87%
Cap/Sales 18.19%
Interest Coverage 9.36
Cash Conversion 277.94%
Profit Quality 425.55%
Current Ratio 0.55
Quick Ratio 0.54
Altman-Z 1.9
F-Score6
WACC8.87%
ROIC/WACC0.58
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y29.89%
Revenue Next 3Y23.88%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year181.9%
EBIT Next 3Y51.76%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A

MDA SPACE LTD / MDA.CA FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 5 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 3 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


What is the profitability of MDA stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


What is the financial health of MDA SPACE LTD (MDA.CA) stock?

The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.


What is the earnings growth outlook for MDA SPACE LTD?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.